Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces that the French version of its 2016 Reference document was filed with the Autorités des Marchés Financiers (AMF), the French stock-market authorities, on March 31st, 2017, under number D.17‑0282.
The 2016 Reference document is available on the Company’s website www.innate-pharma.com (section Investors/Regulated information and publications/Financial reports). Hard copies are available upon request to the investor relations department of the Company.
The Registration document notably includes the following information:
- The 2016 annual financial report;
- The report by the Chairman on the conditions for preparation and organization of the work of the Supervisory Board as well as on internal control;
- The information relating to the Statutory Auditors’ fees.
The English version of the 2016 Reference document will be made available on Innate Pharma’s website during April 2017.